Detection of early stage alzheimer's disease and mild cognitive impairment
AssigneeThe Curators of the University of Missouri
InventorPeter Koulen
Life of this patent
Estimating the term…
Abstract
Systems and methods are described herein for determining that a patient has indications mild cognitive impairment (MCI) or early stage Alzheimer's disease (AD). Microperimetry is used to assess the functional integrity of the patient's retina. Optical Coherence Tomography is used to assess the structural integrity of the patient's retina. Reductions in the size and function of the patient's retina indicate that the patient may have MCI or early stage AD.
Claims13
A computerized method carried out by at least one server having at least one processor for detection of mild cognitive impairment, the method comprising:
- measuring a patient's retinal sensitivity by performing a microperimetry procedure to assess the functional integrity of the patient's retina;
- comparing the retinal sensitivity at a plurality of points within the patient's field of vision with an age matched normal control;
- determining whether the patient's retinal sensitivity is lower than the age matched normal control, and
- determining that the patient has indications of mild cognitive impairment and recommending additional neurological evaluation,
- wherein the patient is determined to have indications of mild cognitive impairment when macular sensitivity of the center of the retina is reduced by at least 20%.
A system for screening a patient for Alzheimer's disease or mild cognitive impairment, the system comprising:
- a microperimeter;
- an optical coherence tomographer;
- a computer having at least one processor, wherein the computer performs the following steps:
- (A) receiving retinal sensitivity data from the microperimeter,
- (B) receiving retinal thickness data from the optical coherence tomographer,
- (C) comparing, with the at least one processor, the retinal sensitivity data and retinal thickness data with age and gender matched control subjects, and
- (D) based on the comparing, determining, with the at least one processor, whether to diagnose the patient with Alzheimer's Disease or mild cognitive impairment, wherein the determining comprises diagnosing a patient with Alzheimer's Disease or mild cognitive impairment when the retinal sensitivity data shows a reduction in sensitivity in the inner macula compared to the age and gender matched control subjects and the retinal thickness data shows a reduction in thickness of the inner macula compared to the age and gender matched control subjects, and wherein the diagnosing a patient with Alzheimer's Disease or mild cognitive impairment comprises diagnosing the patient with Alzheimer's Disease when the retinal sensitivity data shows a reduction in sensitivity of at least 20% of the inner macula and a reduction in sensitivity of at least 10% of the inferior, temporal, and nasal portions of the retina compared to the age and gender matched control subjects.
A computerized method carried out by at least one server having at least one processor for determining that the patient has indications of early stage Alzheimer's disease, the method comprising:
- measuring the patient's retinal sensitivity at a plurality of points by microperimetry;
- comparing the patient's retinal sensitivity at the plurality of points with that of normal patients;
- and
- determining, based on the comparing, the patient has indications of Alzheimer's disease, wherein the determining comprises finding the patient has indications of Alzheimer's Disease when the patient's macular sensitivity of the inner macula is reduced by at least 20% and the patient's macular sensitivity of the inferior, nasal, and temporal portions of the retina are reduced by at least 10% when compared to the normal patients.
Dependencies are inferred from the claim text.